Version 5.4
Bos taurus Protein: HIRA
Summary
InnateDB Protein IDBP-690117.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol HIRA
Protein Name HIR histone cell cycle regulation defective homolog A (S. cerevisiae)
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000026497
InnateDB Gene IDBG-638015 (HIRA)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 19 interaction(s) predicted by orthology.
Predicted by orthology
Total 19 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003682 chromatin binding
GO:0005515 protein binding
Biological Process
GO:0001649 osteoblast differentiation
GO:0006336 DNA replication-independent nucleosome assembly
GO:0006355 regulation of transcription, DNA-templated
GO:0007369 gastrulation
GO:0016568 chromatin modification
GO:0042692 muscle cell differentiation
Cellular Component
GO:0000790 nuclear chromatin
GO:0005634 nucleus
GO:0043234 protein complex
Protein Structure and Domains
PDB ID
InterPro IPR001680 WD40 repeat
IPR011494 TUP1-like enhancer of split
IPR017986 WD40-repeat-containing domain
IPR019015 HIRA B motif
PFAM PF00400
PF07569
PF09453
PRINTS
PIRSF
SMART SM00320
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F1N3C8
UniProt Splice Variant
Entrez Gene 101906870
UniGene Bt.53751
RefSeq XP_005195216
HUGO HGNC:4916
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02045759
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca